Cover Image

Enhancing immunotherapy efficacy against MHC-I deficient triple-negative breast cancer using LCL161-loaded macrophage membrane-decorated nanoparticles

Current cytotoxic T lymphocyte (CTL) activating immunotherapy requires a major histocompatibility complex I (MHC-I)-mediated presentation of tumor-associated antigens, which malfunctions in around half of patients with triple-negative breast cancer (TNBC). Here, we create a LCL161-loaded macrophage...

Full description

Saved in:
Bibliographic Details
Main Authors: Wen Zhang (Author), Yihui Zhai (Author), Ying Cai (Author), Xiang Gong (Author), Yunxuan Jiang (Author), Rong Rong (Author), Chao Zheng (Author), Binyu Zhu (Author), Helen He Zhu (Author), Hao Wang (Author), Yaping Li (Author), Pengcheng Zhang (Author)
Format: Book
Published: Elsevier, 2024-07-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items